Cellectis (CLLS) Other Operating Expenses (2015 - 2026)
Cellectis (CLLS) recorded quarterly Other Operating Expenses of $63000.0 in Q1 2026, up 119.69% quarter-over-quarter from -$320000.0 in Q4 2025, and down 85.21% on a YoY basis from $426000.0 in Q1 2025.
Cellectis (CLLS) Other Operating Expenses (2015 - 2026) Analysis & Trends
Cellectis' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $63000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 85.21% year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $275000.0 (down 77.82% YoY), while the FY2025 annual figure was $849000.0, changed 0.0% from the prior year.
- Other Operating Expenses was $63000.0 for Q1 2026 at Cellectis, up from -$320000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $839000.0 in Q4 2022 to a low of -$1.2 million in Q4 2023.
- Historically, Other Operating Expenses has averaged $102294.1 across 5 years, with a median of $63000.0 in 2026.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 11885.71% in 2022, then slumped 3009.52% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at $839000.0 in 2022, then plunged by 243.5% to -$1.2 million in 2023, then surged by 96.1% to -$47000.0 in 2024, then tumbled by 580.85% to -$320000.0 in 2025, then soared by 119.69% to $63000.0 in 2026.
- The last three Other Operating Expenses figures came in at $63000.0 (Q1 2026), -$320000.0 (Q4 2025), and $154000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | -320,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | 528,000.00 |
| Mar 31, 2023 | -611,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Sep 30, 2022 | -125,000.00 |
| Jun 30, 2022 | 753,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 150,000.00 |